This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Götz Muench: Innovator in Heart Failure Research
Introduction
Götz Muench is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the area of heart failure. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Muench holds a patent titled "Use of EDG2 receptor in an animal model of heart failure." This patent focuses on the application of G protein-coupled receptor EDG2 in mammals and myocardial mammal cells. It presents a novel approach for utilizing these transformed cells in an animal model for heart failure, which could pave the way for new therapeutic strategies.
Career Highlights
Götz Muench is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. His role at Sanofi allows him to engage in cutting-edge research and development, contributing to advancements in medical science. Muench's expertise and innovative mindset have positioned him as a valuable asset in the field.
Collaborations
Muench has collaborated with esteemed colleagues such as Paulus Wohlfart and Kai Rosport. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in healthcare.
Conclusion
Götz Muench's contributions to heart failure research through his patent and work at Sanofi-Aventis Deutschland GmbH highlight his commitment to advancing medical science. His innovative approach and collaborations with other experts in the field underscore the importance of teamwork in achieving breakthroughs in healthcare.